METHOD FOR IDENTIFICATION LONG-TERM MORTALITY RISK AND NEFTAL CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE Russian patent published in 2018 - IPC A61B5/00 

FIELD: medicine.

SUBSTANCE: invention relates to medicine, cardiology. Complaints and anamnesis of disease are collected from patient with chronic coronary heart disease, including therapy, IHD course, presence of severe chronic heart failure, concomitant chronic lung diseases or renal insufficiency, stroke in anamnesis, electro- and echocardiography are conducted. Following indicators are analyzed: complaints of shortness of breath, presence of verified ischemic heart disease, instability of its course: myocardial infarction, acute coronary syndrome, or angina progression in frequency and intensity in the last 3 months; reception of diuretics; presence of a stroke in anamnesis, chronic lung disease or kidney failure, presence of tachycardia on resting ECG, stenosis of aortic valve of atherosclerotic or non-atherosclerotic – congenital or rheumatic origin, violations of diastolic function and decrease in contractility of myocardium of the left ventricle according to echocardiography. Risk index of remote death and nonfatal cardiovascular complications (RINDEX) is calculated in the patients with chronic ischemic heart disease is derived as a total score of all the criteria. Mortality risk and nonfatal cardiovascular complications is correlated with derived RINDEX value.

EFFECT: method allows accurate assessing of mortality risk and cardiovascular complications, choosing optimal tactics for diagnosis and treatment, resolving problem of priority of direction a patient with high risk to high-tech treatments.

1 cl, 3 ex